Oct. 12, 2020 Price forecast | 2 weeks: -2.71% | 1 month: -4.54% | 3 months: -6.15%


RAPT stock forecast

Our latest prediction for Rapt Therapeutics, Inc.'s stock price was made on the Oct. 12, 2020 when the stock price was at 40.23$.

In the short term (2weeks), RAPT's stock price should underperform the market by -2.71%. During that period the price should oscillate between -11.59% and +12.91%.

In the medium term (3months), RAPT's stock price should underperform the market by -6.15%. During that period the price should oscillate between -40.22% and +28.72%.

Create a solid portfolio with RAPT

Add RAPT to your portfolio and optimize it!


About Rapt Therapeutics, Inc.

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.

At the moment the company generates 2M USD in revenues.

On its last earning announcement, the company reported a loss of -1.99$ per share.

The book value per share is 3.00$

Rapt Therapeutics, Inc. website


Three months stock forecastOct. 12, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
2M - -49M - -49M -1.99 - - 24M 3.00 -33M - -33M